According to a recent publication by Meticulous Research®, the global continuous glucose monitoring (CGM) market is projected to experience significant growth, reaching an estimated $31.41 billion by 2031. The market is expected to expand at a compound annual growth rate (CAGR) of 15% over the forecast period of 2024–2031.
Download free sample report here:https://www.meticulousresearch.com/download-sample-report/cp_id=5960
Several key factors are driving this growth, including the increasing prevalence of diabetes, the rising number of people leading sedentary lifestyles, and the superior benefits offered by CGM systems compared to traditional glucose monitoring methods. Additionally, the growing adoption of CGM devices among athletes and fitness enthusiasts, coupled with technological advancements, is contributing to market expansion. A shift towards personalized healthcare, increased health awareness, and improved accessibility to diabetes care devices, particularly in low and middle-income countries, are expected to provide further growth opportunities in the coming years.
Market Drivers and Opportunities
The increasing prevalence of diabetes is one of the most significant drivers of the CGM market. Diabetes has become a global health concern, with millions of people being diagnosed with the condition each year. The World Health Organization (WHO) estimates that over 422 million people worldwide are living with diabetes, a number that is expected to rise significantly in the coming decades. As the number of people with diabetes continues to grow, so does the demand for effective monitoring and management solutions. CGM systems, which provide real-time glucose readings and trends, offer a more comprehensive and convenient way to monitor blood glucose levels compared to traditional finger-stick methods. This real-time data allows for better management of the condition, leading to improved health outcomes and reduced complications.
Another factor contributing to the growth of the CGM market is the increasing number of people living sedentary lifestyles. Sedentary behavior is associated with a higher risk of developing type 2 diabetes, as well as other chronic conditions such as cardiovascular disease and obesity. As more people adopt sedentary lifestyles, the incidence of diabetes is expected to rise, further driving the demand for CGM systems.
Technological advancements in CGM devices are also playing a crucial role in market growth. Innovations such as smaller, more comfortable sensors, longer sensor wear times, and improved accuracy have made CGM systems more user-friendly and appealing to a broader audience. Additionally, the integration of CGM devices with smartphone apps and other digital health platforms has enhanced the user experience, making it easier for patients to track their glucose levels and share data with healthcare providers.
Browse in depth: https://www.meticulousresearch.com/product/continuous-glucose-monitoring-market-5960
The shift towards personalized healthcare is another trend that is expected to drive the CGM market. Personalized healthcare involves tailoring medical treatment and management strategies to the individual needs of each patient. CGM systems enable personalized care by providing detailed insights into a patient’s glucose patterns and trends, allowing healthcare providers to make more informed decisions about treatment and management strategies.
Key Market Players
The report provides a comprehensive analysis of the leading players in the CGM market, including their product portfolios, geographic presence, and growth strategies. Over the past three to four years, the market has witnessed several organic and inorganic strategic developments. Key players profiled in the report include DexCom, Inc. (U.S.), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (U.K.), LifeScan, Inc. (U.S.), Senseonics Holdings, Inc. (Maryland), A. Menarini Diagnostics S.r.l (Italy), Medtrum Technologies, Inc. (China), and B. Braun Melsungen SE (Germany).
These companies have been at the forefront of innovation in the CGM market, developing new products and technologies to meet the evolving needs of patients and healthcare providers. For example, DexCom’s G6 CGM system has been widely recognized for its accuracy, ease of use, and integration with various digital health platforms. Similarly, Abbott’s FreeStyle Libre system has gained popularity due to its affordability and user-friendly design.
Market Segmentation
The continuous glucose monitoring market is segmented based on components, age groups, end users, and geography. The components segment includes sensors (both disposable and implantable), transmitters, and receivers. Among these, the sensors segment is expected to account for the largest share of the market, with a projected share of 52.4% in 2024. This dominance can be attributed to technological advancements in sensor technology, the availability of disposable sensors, and the growing adoption of CGM devices over traditional glucometers. Sensors are a critical component of CGM systems and are often replaced more frequently than other components, leading to higher sales and market share.
Download request sample report here:https://www.meticulousresearch.com/request-sample-report/cp_id=5960
In terms of age groups, the adults segment is expected to hold the largest share of the CGM market in 2024. This can be attributed to the high prevalence of diabetes among adults, the increasing adoption of wearable health devices, and a growing focus on preventive healthcare. The number of adults living with diabetes is significantly higher than that of children, leading to greater demand for CGM systems in this demographic.
The end-user segment is divided into home care settings and hospitals & clinics. Among these, the home care settings segment is expected to account for the largest share of the market, with an estimated share of over 82.3% in 2024. The rising geriatric population, coupled with the growing burden of diabetes, has increased the need for self-monitoring and home care solutions. CGM systems designed for home use offer several benefits, including easy accessibility, reduced time and costs associated with hospital visits, increased patient engagement, and a shift towards preventive healthcare.
Regional Insights
Geographically, the CGM market is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, North America is expected to hold the largest share of the market, accounting for over 42.2%. The region’s dominance can be attributed to several factors, including a high level of patient engagement, a shift towards preventive care, and high awareness and accessibility to CGM systems. Additionally, the availability of reimbursement for CGM devices, particularly in the U.S., has played a significant role in driving market growth.
For instance, a study conducted by One Drop (U.S.), a precision health solutions provider, revealed that approximately 2.4 million people in the U.S. were using CGM devices in 2022. This number is expected to increase substantially in the coming years, further boosting the market share in North America.
Conclusion
The continuous glucose monitoring market is poised for significant growth over the next decade, driven by the increasing prevalence of diabetes, technological advancements, and a shift towards personalized healthcare. Key market players are expected to continue innovating and expanding their product offerings to meet the growing demand for CGM systems. As the market evolves, opportunities for growth are expected to arise in both developed and emerging markets, making the CGM market a critical area of focus for healthcare companies and investors alike.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian